AnaptysBio: , Including Exhibit 99.1 To This Current Report On Form 8k, Shall Not Be Deemed To Be “filed” For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Otherwise Subject To The Liabilities Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended. The Information Contained In This Item 2.02 And In The Accompanying Exhibit 99.1 Shall Not Be Incorporated By Reference Into Any Registration Statement Or Other Document Filed By Anaptysbio With The Securities And Exchange Commission, Whether Made Before Or After The Date Of This Current Report On Form 8k, Regardless Of Any General Incorporation Language In Such Filing (or Any Reference To This Current Report On Form 8k Generally), Except As Shall Be Expressly Set Forth By Specific Reference In Such Filing, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  AnaptysBio, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***